These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4106805)

  • 1. An eosinophil leukocyte chemotactic factor of anaphylaxis.
    Kay AB; Stechschulte DJ; Austen KF
    J Exp Med; 1971 Mar; 133(3):602-19. PubMed ID: 4106805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Kay AB; Shin HS; Austen KF
    Immunology; 1973 Jun; 24(6):969-76. PubMed ID: 4123965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of eosinophil chemotactic factor of anaphylaxis (ECF-A) from guinea pig skin.
    Kimura I; Yamamoto S; Yamura T
    Int Arch Allergy Appl Immunol; 1979; 60(4):465-8. PubMed ID: 91587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.
    Kay AB
    Antibiot Chemother (1971); 1974; 19():271-83. PubMed ID: 4142850
    [No Abstract]   [Full Text] [Related]  

  • 5. Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgG1 or IgE antibodies.
    Undem BJ; Buckner CK; Harley P; Graziano FM
    Am Rev Respir Dis; 1985 Feb; 131(2):260-6. PubMed ID: 2578761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.
    Goetzl EJ; Austen KF
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4123-7. PubMed ID: 1060093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R; Cromwell O; Taylor GW; Kay AB
    J Immunol; 1991 Oct; 147(7):2276-83. PubMed ID: 1655889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator release from basophil granulocytes in chronic myelogenous leukemia.
    Clark RA; Gallin JI; Kaplan AP
    J Allergy Clin Immunol; 1976 Dec; 58(6):623-34. PubMed ID: 62774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ; Austen KF
    Monogr Allergy; 1977; 12():189-97. PubMed ID: 335214
    [No Abstract]   [Full Text] [Related]  

  • 11. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A).
    Wasserman SI; Goetzl EJ; Austen KF
    J Immunol; 1974 Jan; 112(1):351-8. PubMed ID: 4812176
    [No Abstract]   [Full Text] [Related]  

  • 13. Passive sensitization of guinea-pig skin in vitro for the antigen-induced release of anaphylactic mediators.
    Jones DG; Kay AB
    Clin Exp Immunol; 1974 Feb; 16(2):213-22. PubMed ID: 4143274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.
    Stechschulte DJ; Austen KF; Bloch KJ
    J Exp Med; 1967 Jan; 125(1):127-47. PubMed ID: 4163357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA; Goetzl EJ; Wasserman SI; Valone FH; Rubin RH; Austen KF
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mediators of the allergic reaction. Slow reacting substance (SRS-A)].
    Naranjo P
    Allergol Immunopathol (Madr); 1975; 3(4):239-54. PubMed ID: 5879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.
    Kay AB; Austen KF
    J Immunol; 1971 Sep; 107(3):899-902. PubMed ID: 4105937
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in responses of rat- and guinea-pig-eosinophils to eosinophil chemotactic factors derived from Angiostrongylus cantonensis.
    Ishida K; Yoshimura K
    Parasite Immunol; 1990 May; 12(3):269-83. PubMed ID: 2385443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue.
    Austen KF
    Fed Proc; 1974 Nov; 33(11):2256-62. PubMed ID: 4139041
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.